IL6 and left ventricular hypertrophy: The previous study reported that IL-6 deletion attenuated the left ventricular hypertrophy and dysfunction induced by 6-week TAC in mice and proved that both angiotensin II- and phenylephrine-induced increase in hypertrophy genes were abrogated in IL-6-/- cardiac myocyte [13].